Ingevity Corporation

NYSE:NGVT

Chemicals - Specialty

Basic Materials
$58.31 +1.13%

+$0.81 today

Market cap
$1.97B
Beta
1.19
P/E (TTM)
-20.0
EPS (TTM)
-$3.62
52W Low $39.74High $79.29

Volume 0.37M

Average 0.26M

NGVT Accounts Receivables

Cash effect of the change in amounts owed by customers; growing receivables consume cash.

Ingevity CorporationNYSE: NGVT

Accounts Receivables · Q3 FY2026 · quarter ended Sep 2026

Accounts receivables outflow shrinks to $0

Q3 FY2026 accounts receivables was $0, compared with $15.2M a year earlier. Trailing-twelve-month accounts receivables was $5.1M.

Context

  • Accounts receivables amounted to 1.0% of revenue in FY2025, down 1.7 pp from a year earlier.
  • Accounts receivables increased in 1 of the last 3 fiscal years.

What to watch

Whether quarterly accounts receivables holds near $0 or moves back toward the trailing-twelve-month quarterly average of $1.28M.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterSep 2026
$0+100.0% QoQ
Last fiscal yearDec 2025
$12.2M-68.1% YoY
LTMSep 2026
$5.1M-54.9% YoY
Accounts Receivables past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-100.0%——
1 year-68.1%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Accounts Receivables history

USD · from the cash flow

Latest · FY2025
12.2M USD
Year-over-year change
-68.1%

Accounts Receivables vs competitors

How NGVT compares with its peers on the latest reported figures

  • Peers report in different currencies, so accounts receivables is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of -54.9% is the 6th highest of 9, against a peer median of +87.6%.
  • Accounts receivables amounts to 0.5% of revenue for NGVT, versus a peer median of 2.6%.
NGVT Competitors
Accounts Receivables for NGVT and competitors
Company Period LTM YoY 3-year CAGR% of revenue
FMCFMC CorporationLTM Mar 2026$129.2M USD+169.6%—3.8%
AAUCAllied Gold CorporationLTM Jun 2026$97.36M USD+58.0%+56.7%6.5%
IOSPInnospec Inc.LTM Jun 2026$91.2M USD+328.2%—5.0%
OLNOlin CorporationLTM Jun 2026$83.9M USD+172.3%-8.4%1.3%
KWRQuaker Chemical CorporationLTM Sep 2026$53.27M USD-696.2%—2.6%
ELVRElevra Lithium LimitedFY2025A$32.31M AUD——15.6%
CCThe Chemours CompanyLTM Jun 2026$15M USD-61.5%+5.2%0.3%
NGVTIngevity CorporationLTM Sep 2026$5.1M USD-54.9%—0.5%
SKESkeena Resources LimitedLTM Sep 2026CA$1.25M CAD+117.2%——
ASHAshland Inc.LTM Jun 2026$0 USD-100.0%—0.0%
MTXMinerals Technologies Inc.LTM Apr 2026$0 USD—-52.4%0.0%
Peer median (excluding NGVT) —+87.6%-1.6%2.6%

Competitors are the stored peer set for NGVT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income118.1M211.6M(5.4M)(430.3M)(167.1M)
Depreciation & Amortization109.9M108.8M122.8M108.3M106.4M
Deferred Income Tax(4.6M)(5M)(44.7M)(121.4M)(4.7M)
Stock-Based Compensation12.3M16.1M10.6M11.9M18.3M
Change in Working Capital30.5M(66.5M)(67.8M)(10M)22.7M
Accounts Receivables(13.8M)(42.1M)42.7M38.2M12.2M
Inventory(55.8M)(63.7M)25.8M86.2M40.2M
Accounts Payables14.8M42.7M(14.6M)(63.4M)(2.6M)
Other Working Capital85.3M(3.4M)(121.7M)(71M)(27.1M)
Other Non-Cash Items27.1M48.4M189.6M570.1M355.6M
Operating Cash Flow293.3M313.4M205.1M128.6M331.2M
Capital Expenditures(103.8M)(142.5M)(109.8M)(77.6M)(57.7M)
Acquisitions (Net)0(344.5M)000
Purchases of Investments(35.3M)(77.4M)(2.4M)(300K)(16.4M)
Sales of Investments014.7M31.5M013M
Other Investing Activities500K(2.2M)3.4M(1.6M)3.6M
Investing Cash Flow(138.6M)(551.9M)(77.3M)(79.5M)(57.5M)
Debt Repayment(26M)199M(6.6M)(67.1M)(193.6M)
Common Stock Issued4.7M04.7M01.4M
Common Stock Repurchased(109.4M)(145.2M)(92.1M)(3.1M)(56.3M)
Dividends Paid00000
Other Financing Activities(2.4M)(5.7M)(5.9M)0(3.7M)
Financing Cash Flow(133.1M)48.1M(99.9M)(70.2M)(252.2M)
Effect of Forex Changes(1.7M)(6M)(300K)(4.2M)4.5M
Net Change in Cash19.9M(196.4M)27.6M(25.3M)26M
Free Cash Flow189.5M170.9M95.3M51M273.5M

Ingevity Corporation

NYSE:NGVT

Intrinsic Alpha fair value

Locked

Current Price

$58.31

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.